NDLI: Etanercept in the Treatment of Intestinal Behcet’s Disease

Content Provider	Springer Nature Link
Author	Ma, Dan Zhang, Chao Jun Wang, Ru Peng Wang, Lie Yang, Hua
Copyright Year	2014
Abstract	Behcet’s disease (BD) accompanied by intestinal involvement is called intestinal BD. Although recent studies have attained positive feedback with the administration of anti-TNF-α agents in patients with BD, only a few reports on the study of etanercept in intestinal BD have been found. In this study, 35 cases of intestinal BD were treated with conventional therapy (prednisone or methotrexate) for a minimum period of 3 months (group 1). Another 19 patients who failed to respond to conventional therapy were then treated with etanercept (25 mg twice a week for 3 months). During each subsequent relapse, the patients were given the same treatment. The main outcome measures were the four criteria for diagnosis of BD (buccal ulcers, genital ulcers, ocular lesions, and skin lesions), the manifestation of intestinal involvement (abdominal symptoms, double-balloon enteroscopy), laboratory examinations of the acute phase reactants (erythrocyte sedimentation rate) and C-reactive protein, and relapses. As a result of the administered therapy, the healing rate of buccal and genital ulcers, the remission rate of ocular lesions, skin lesions, and abdominal symptoms, the healing rate of intestinal ulcers, and the recovery rate of ESR and CRP were significantly higher in group 2 than those of group 1. The relapse rate in the etanercept therapy was reduced significantly when compared with conventional therapy group. In conclusion, etanercept treatment, in contrast to the conventional therapy, can result in better curative effect and less adverse reactions in intestinal BD.
Starting Page	735
Ending Page	739
Page Count	5
File Format	PDF
ISSN	10859195
Journal	Cell Biochemistry and Biophysics
Volume Number	69
Issue Number	3
e-ISSN	15590283
Language	English
Publisher	Springer US
Publisher Date	2014-03-13
Publisher Place	Boston
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Behcet’s disease Treatment Etanercept Biochemistry Pharmacology/Toxicology Biotechnology Cell Biology Biophysics and Biological Physics
Content Type	Text
Resource Type	Article
Subject	Cell Biology Medicine Biochemistry Biophysics

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Surgical Treatment of Hashimoto’s with Thyroid Microcarcinoma

The Transurethral Seminal Vesiculoscopy in the Diagnosis and Treatment of the Seminal Vesicle Disease

Special Issue on Oxidative Stress in Health and Disease

Polyphenols in Health and Disease

Effect of Subthalamic Nuclei Electrical Stimulation in the Treatment of Parkinson’s Disease

EiC's Introductory Letter

Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease

2014 AHA/ACC Guideline for the Patients with Valvular Heart Disease

A Baker’s Dozen of Ubiquitin

Etanercept in the Treatment of Intestinal Behcet’s Disease

Similar Documents

Surgical Treatment of Hashimoto’s with Thyroid Microcarcinoma

The Transurethral Seminal Vesiculoscopy in the Diagnosis and Treatment of the Seminal Vesicle Disease

Special Issue on Oxidative Stress in Health and Disease

Polyphenols in Health and Disease

Effect of Subthalamic Nuclei Electrical Stimulation in the Treatment of Parkinson’s Disease

EiC's Introductory Letter

Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease

2014 AHA/ACC Guideline for the Patients with Valvular Heart Disease

A Baker’s Dozen of Ubiquitin

Etanercept in the Treatment of Intestinal Behcet’s Disease